Martingale Asset Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Sell	65,926 -532	-0.8%	-$9.41K	0.03%	479
2025 Q4	$1.24M	Sell	66,458 -4,508	-6%	-$74.8K	0.03%	428
2025 Q3	$1.04M	Buy	70,966 +2,125	+3%	+$26.9K	0.03%	468
2025 Q2	$759K	Buy	68,841 +7,511	+12%	+$73K	0.02%	526
2025 Q1	$548K	Buy	61,330 +2,680	+5%	+$24.9K	0.01%	583
2024 Q4	$552K	Buy	58,650 +4,200	+8%	+$38.2K	0.01%	586
2024 Q3	$439K	Buy	54,450 +6,870	+14%	+$59.5K	0.01%	654
2024 Q2	$403K	Buy	47,580 +16	+0%	+$144	0.01%	645
2024 Q1	$427K	Sell	47,564 -1,100	-2%	-$10.2K	0.01%	643
2023 Q4	$547K	Sell	48,664 -30,020	-38%	-$302K	0.01%	592
2023 Q3	$679K	Hold	78,684	–	–	0.01%	542
2023 Q2	$814K	Buy	78,684 +1,901	+2%	+$21K	0.02%	500
2023 Q1	$833K	Buy	76,783 +16,041	+26%	+$170K	0.02%	490
2022 Q4	$682K	Buy	+60,742	New	+$638K	0.01%	565
2020 Q4	–	Sell	-11,200	Closed	-$166K	–	1038
2020 Q3	$166K	Buy	11,200 +1,400	+14%	+$26.2K	﹤0.01%	987
2020 Q2	$206K	Buy	+9,800	New	+$252K	﹤0.01%	989